CorWave

CorWave develops blood pumps based on a unique and patented wave membrane pumping technology. The membrane is the result of more than twenty years of research and development, and is capable of mimicking the native heart. This disruptive technology radically differentiates CorWave products from commercially-available rotary pump LVADs.

Sector
Medical Devices
Strategies
MD Start & Capital
Status
Active
Website
www.corwave.com

9 October, 2023
CorWave announces the Grand opening of Its manufacturing facility on the banks of the Seine, next to Paris
17 March, 2022
CorWave to set up its manufacturing facility and expand to a new site next to Paris
2 February, 2022
5 Sofinnova Partners portfolio companies selected to French Tech 120
6 January, 2021
CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor
21 July, 2020
CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program
10 July, 2018
CorWave’s next-generation LVAD, Neptune, receives funding

SofinnovaCapital

The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.

SofinnovaMD Start

The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.

SofinnovaCrossover

The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.

SofinnovaIndustrial Biotech

Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.

SofinnovaTelethon

The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.

SofinnovaDigital Medicine

The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.

CorWave announces the Grand opening of Its manufacturing facility on the banks of the Seine, next to Paris

CorWave to set up its manufacturing facility and expand to a new site next to Paris

5 Sofinnova Partners portfolio companies selected to French Tech 120

CorWave Raises €35 Million in Series C Funding for Its Breakthrough Heart Pump; EIC Fund Joins as New Investor

CorWave Awarded €2.5M From the European Commission Through the EIC Accelerator Program

CorWave’s next-generation LVAD, Neptune, receives funding